A detailed history of Farther Finance Advisors, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 485 shares of TMDX stock, worth $29,594. This represents 0.0% of its overall portfolio holdings.

Number of Shares
485
Previous 169 186.98%
Holding current value
$29,594
Previous $25.4 Million 200.13%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$135.68 - $176.11 $42,874 - $55,650
316 Added 186.98%
485 $76.2 Million
Q2 2024

Jul 31, 2024

BUY
$72.62 - $150.62 $2,033 - $4,217
28 Added 19.86%
169 $25.4 Million
Q1 2024

May 13, 2024

BUY
$70.86 - $89.93 $8,857 - $11,241
125 Added 781.25%
141 $10.4 Million
Q4 2023

Feb 14, 2024

BUY
$36.74 - $81.08 $587 - $1,297
16 New
16 $1.26 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.94B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.